Patents-Review.com
ClassID:

110540 ⎘

C12N2750/14133 - CPC Classification

Classification description:

ssDNA viruses; Details; Parvoviridae; Dependovirus, e.g. adenoassociated viruses Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Recent Application in this class:
#1
20260077026
2026-03-19

METHODS FOR TREATING CANCER WITH HYPERACTIVE ADAR ENZYMES

 #2
20250304918
2025-10-02

VIRAL PARTICLES RETARGETED TO SKELETAL MUSCLE

 #3
20250288644
2025-09-18

Gene Therapy For Neurodegenerative Disorders

 #4
20250163469
2025-05-22

ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS AND METHODS OF USE THEREOF

 #5
20250011783
2025-01-09

GENE THERAPY FOR NEURODEGENERATIVE DISORDERS

 #6
20240350584
2024-10-24

Gene Therapy For Neurodegenerative Disorders

 #7
20240301008
2024-09-12

MODIFIED AAV CAPSIDS AND USES THEREOF

 #8
20240287471
2024-08-29

GENE THERAPIES FOR LYSOSOMAL DISORDERS

 #9
20240238446
2024-07-18

TREATMENT OF COMPLEMENT-MEDIATED DISORDERS

 #10
20240197915
2024-06-20

METHODS OF TREATING OCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT

 #11
20240066102
2024-02-29

Genome editing approaches to treat Spinal Muscular Atrophy

 #12
20240033323
2024-02-01

Gene Therapy For Neurodegenerative Disorders

 #13
20230279435
2023-09-07

Adeno-associated virus variant capsids and methods of use thereof

 #14
20230190956
2023-06-22

METHODS FOR PREVENTING INDUCTION OF IMMUNE RESPONSES TO THE TRANSDUCED CELLS EXPRESSING A TRANSGENE PRODUCT AFTER OCULAR GENE THERAPY

 #15
20230181683
2023-06-15

PEPTIDES HAVING SPECIFICITY FOR THE LUNGS

 #16
20230171886
2023-06-01

CIRCUIT BOARD

 #17
20230144548
2023-05-11

RECOMBINANT AAV VECTORS WITH ALTERED IMMUNOGENCITY AND METHODS OF MAKING THE SAME

 #18
20230142867
2023-05-11

AAV NATIVE-NEURO PLATFORM AND USE FOR NEURONAL DISEASE GENE THERAPY

 #19
20230135379
2023-05-04

Gene therapy for neurodegenerative disorders

 #20
20230084580
2023-03-16

Gene therapy for neurodegenerative disorders

 #21
20220347320
2022-11-03

REGENERATION OF RETINAL GANGLION CELLS

 #22
20220251145
2022-08-11

Adeno-associated virus variant capsids and methods of use thereof

 #23
20220227816
2022-07-21

Modified AAV capsids and uses thereof

 #24
20220193252
2022-06-23

RAAV WITH CHEMICALLY MODIFIED CAPSID

 #25
20220088222
2022-03-24

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES

 #26
20220064668
2022-03-03

MODIFIED ADENO-ASSOCIATED VIRAL VECTORS FOR USE IN GENETIC ENGINEERING

 #27
20220033824
2022-02-03

MODULATION OF SPTLC1 VIA RECOMBINANT ADENO-ASSOCIATED VECTORS

 #28
20220010335
2022-01-13

Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells

 #29
20210380643
2021-12-09

Adeno-associated virus variant capsids and methods of use thereof

 #30
20210363193
2021-11-25

MODIFIED AAV CAPSID POLYPEPTIDES FOR TREATMENT OF MUSCULAR DISEASES

 #31
20210355171
2021-11-18

ADENO-ASSOCIATED VIRUS HAVING A VARIANT CAPSID PROTEIN, AND USE THEREOF

 #32
20210338752
2021-11-04

Adeno-associated virus purification methods

 #33
20210284699
2021-09-16

ADENO-ASSOCIATED VIRAL CAPSIDS WITH EXPANDED SIZES

 #34
20210283271
2021-09-16

rAAV with chemically modified capsid

 #35
20210205467
2021-07-08

RAAV with chemically modified capsid

 #36
20210187062
2021-06-24

PEPTIDES HAVING SPECIFICITY FOR THE LUNGS

 #37
20210054410
2021-02-25

Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells

 #38
20210038591
2021-02-11

VIRAL VECTOR TRANSDUCTION

 #39
20200405639
2020-12-31

NOVEL DELIVERY OF LARGE PAYLOADS

 #40
20200384076
2020-12-10

GENE THERAPY FOR NEURODEGENERATIVE DISORDERS

 #41
20200332265
2020-10-22

Gene therapies for lysosomal disorders

 #42
20200318115
2020-10-08

Gene therapy for neurodegenerative disorders

 #43
20200268907
2020-08-27

Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter

 #44
20200231970
2020-07-23

Gene therapies for lysosomal disorders

 #45
20200147240
2020-05-14

TREATMENT OF COMPLEMENT-MEDIATED DISORDERS

 #46
20200095559
2020-03-26

Adeno-associated virus capsid variants and methods of use thereof

 #47
20190388557
2019-12-26

RAAV with chemically modified capsid

 #48
20190365928
2019-12-05

Compositions and methods for the expression of CRISPR guide RNAS using the H1 promoter

 #49
20190365835
2019-12-05

Adeno-associated virus purification methods

 #50
20190345208
2019-11-14

Methods and compositions for treating hemophilia

 #51
20190276849
2019-09-12

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

 #52
20190276848
2019-09-12

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

 #53
20190202866
2019-07-04

VIRAL NANOPARTICLES AND METHODS OF USE THEREOF

 #54
20190194689
2019-06-27

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

 #55
20190194688
2019-06-27

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

 #56
20190153034
2019-05-23

Viral vector for the targeted transfer of genes in the brain and spinal cord

 #57
20190135870
2019-05-09

Adeno-associated virus polynucleotides, polypeptides and virions

 #58
20190024116
2019-01-24

Vector

 #59
20180369420
2018-12-27

Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter

 #60
20180362601
2018-12-20

Methods and compositions for genome engineering

 #61
20180250422
2018-09-06

METHODS OF TREATING NEURODEGENERATIVE DISORDERS

 #62
20180200388
2018-07-19

Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter

 #63
20180148738
2018-05-31

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

 #64
20180127471
2018-05-10

Modified AAV capsids and uses thereof

 #65
20170349911
2017-12-07

CNS targeting AAV vectors and methods of use thereof

 #66
20170348386
2017-12-07

METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES

 #67
20170342118
2017-11-30

Methods and compositions for treating hemophilia

 #68
20170173181
2017-06-22

Methods of treating neurodegenerative disorders

 #69
20170087212
2017-03-30

Gene therapy for neurodegenerative disorders

 #70
20170029464
2017-02-02

Viral vector for the targeted transfer of genes in the brain and spinal cord

 #71
20160175389
2016-06-23

Peptides having specificity for the lungs

 #72
20160122727
2016-05-05

MESSENGER RNA BASED VIRAL PRODUCTION

 #73
20160074535
2016-03-17

Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter

 #74
20160074533
2016-03-17

VECTOR ENCODING THERAPEUTIC POLYPEPTIDE AND SAFETY ELEMENTS TO CLEAR TRANSDUCED CELLS

 #75
20160051699
2016-02-25

Gene therapy for neurodegenerative disorders

 #76
20150216999
2015-08-06

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASES USING SMAD3

 #77
20150166618
2015-06-18

Methods and compositions for treating hemophilia

 #78
20150159172
2015-06-11

Methods and compositions for genome engineering

 #79
20140335054
2014-11-13

CNS targeting AAV vectors and methods of use thereof

 #80
20140056854
2014-02-27

Viral vectors with modified transduction profiles and methods of making and using the same

 #81
20130195801
2013-08-01

CNS targeting AAV vectors and methods of use thereof

 #82
20120213736
2012-08-23

Parvovirus methods and compositions for killing neoplastic cells

 #83
20100233200
2010-09-16

VECTOR ENCODING THERAPEUTIC POLYPEPTIDE AND SAFETY ELEMENTS TO CLEAR TRANSDUCED CELLS

 #84
20090162332
2009-06-25

Methods and compositions for treating brain diseases